Effects and safety of infliximab administration in refractory uveoretinitis with Behçet's disease

Nippon Ganka Gakkai zasshi

Volumn 114, Issue 2, 2010, Pages 87-95

  Tanaka, Hiroyuki ^a   Sugita, Sunao ^a   Yamada, Yukiko ^a   Kawaguchi, Tatsushi ^a   Iwanaga, Yoichi ^a   Kamoi, Koju ^a   Yokota, Mako ^a   Takase, Hiroshi ^a   Mochizuki, Manabu ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT; INFLIXIMAB; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BEHCET DISEASE; CLINICAL TRIAL; FEMALE; HUMAN; IMMUNOLOGY; INTRAVENOUS DRUG ADMINISTRATION; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; RETINITIS; RETROSPECTIVE STUDY; TREATMENT OUTCOME; UVEITIS; VISUAL ACUITY;

ADULT; AGED; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; BEHCET SYNDROME; CLINICAL TRIALS AS TOPIC; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; RETINITIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA; UVEITIS; VISUAL ACUITY;

EID: 77950356284     PISSN: 00290203     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)